Search results
8 lis 2023 · Alfasigma is one of Italy’s leading pharmaceutical companies with a strong international position. The Group has a worldwide presence in over 100 countries where about 3000 people work in research, development, production and distribution.
11 paź 2023 · Alfasigma S.p.A. tender offer for Intercept Pharmaceuticals, Inc. commences. October 11, 2023.
8 lis 2023 · Alfasigma S.p.A. successfully completes tender offer for all outstanding shares of common stock of Intercept Pharmaceuticals, Inc. Business Wire. Wed, Nov 8, 2023 5 min read. BOLOGNA, Italy...
8 lis 2023 · Bologna, Italy & Morristown, N.J., U.S. – November 8, 2023 – Alfasigma S.p.A. (“Alfasigma”) and Intercept Pharmaceuticals, Inc. ( “Intercept”) announced today the completion of the acquisition of Intercept by Alfasigma through its wholly owned subsidiary Interstellar Acquisition Inc.
26 wrz 2023 · Intercept Pharmaceuticals (ICPT) to be acquired by Alfasigma in an $800M deal, offering a premium to its IPO price. Read why this deal is good for Alfasigma.
26 wrz 2023 · Under the terms of the merger agreement, Alfasigma has agreed to commence a cash tender offer to acquire all issued and outstanding shares of Intercept common stock for US$19.00 per share in...
26 wrz 2023 · Intercept Pharmaceuticals (NASDAQ: ICPT) added ~79% pre-market Tuesday after the Italian pharmaceutical company Alfasigma agreed to acquire it for $19.00 per share in cash. The acquisition will...
